Author headshot
FOLLOW

Amesh A. Adalja, MD

Adalja is an infectious disease, bioterrorism and emergency medicine specialist and senior scholar at the Johns Hopkins Center for Health Security.

Most recent by Amesh A. Adalja, MD

SPONSORED CONTENT
April 24, 2025
3 min read
Save

Baloxavir trial suggests influenza PEP for household contacts may be effective

Baloxavir trial suggests influenza PEP for household contacts may be effective

A trial of the influenza antiviral baloxavir suggests that the drug could be used as post-exposure prophylaxis to prevent infection among household contacts of someone infected with the virus.

SPONSORED CONTENT
September 20, 2024
1 min read
Save

FDA approves nasal spray as first self-administered flu vaccine

FDA approves nasal spray as first self-administered flu vaccine

The FDA on Friday approved the first ever influenza vaccine that does not have to be given by a health care professional.

SPONSORED CONTENT
July 02, 2024
2 min read
Save

US gives Moderna $176 million to develop mRNA pandemic flu vaccine

US gives Moderna $176 million to develop mRNA pandemic flu vaccine

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

SPONSORED CONTENT
March 29, 2024
2 min read
Save

Moderna announces positive interim results for next-generation COVID-19 vaccine

Moderna announces positive interim results for next-generation COVID-19 vaccine

Moderna announced positive interim results from a phase 3 trial of its next-generation COVID-19 vaccine, which the company said will help pave the way for its combination shot against COVID-19 and influenza.

SPONSORED CONTENT
March 01, 2024
2 min read
Save

CDC: People with COVID-19 no longer have to isolate for 5 days

CDC: People with COVID-19 no longer have to isolate for 5 days

The CDC said Friday that people with COVID-19 no longer have to isolate for 5 days if they are showing certain signs of improvement — the first time in more than 2 years that the guidance has been updated.

SPONSORED CONTENT
February 01, 2024
2 min read
Save

Updated COVID-19 vaccines effective against variants, new data show

Updated COVID-19 vaccines effective against variants, new data show

The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection and offered protection against JN.1 and XBB viral lineages, according to early estimates published Thursday by the CDC.

SPONSORED CONTENT
November 13, 2023
2 min read
Save

COVID-19 rebounds in one in five Paxlovid users

COVID-19 rebounds in one in five Paxlovid users

About 20% of patients with COVID-19 experienced virologic rebound after receiving Paxlovid, according to an observational study published in Annals of Internal Medicine.

SPONSORED CONTENT
October 24, 2023
2 min read
Save

FDA will review self-administered flu vaccine for approval

FDA will review self-administered flu vaccine for approval

The FDA is set to review what could be the country’s first self-administered influenza vaccine.

SPONSORED CONTENT
May 12, 2023
2 min read
Save

Q&A: What impact did ID experts have on the COVID-19 pandemic?

Q&A: What impact did ID experts have on the COVID-19 pandemic?

Throughout the COVID-19 pandemic, infectious disease experts made contributions to help control the outbreak and improve public understanding of the new disease.

SPONSORED CONTENT
May 05, 2023
2 min read
Save

WHO says COVID-19 no longer a global public health emergency

WHO says COVID-19 no longer a global public health emergency

WHO said Friday that the COVID-19 pandemic no longer constitutes a global public health emergency of international concern, citing reduced risks to human health driven by high population-level immunity and vaccination.